MX9704061A - Bacterias productoras de rtx atenuadas vivas de la familia pasteurellaceae. - Google Patents
Bacterias productoras de rtx atenuadas vivas de la familia pasteurellaceae.Info
- Publication number
- MX9704061A MX9704061A MX9704061A MX9704061A MX9704061A MX 9704061 A MX9704061 A MX 9704061A MX 9704061 A MX9704061 A MX 9704061A MX 9704061 A MX9704061 A MX 9704061A MX 9704061 A MX9704061 A MX 9704061A
- Authority
- MX
- Mexico
- Prior art keywords
- producing bacteria
- pasteurellaceae family
- living attenuated
- rtx
- living
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 241000606752 Pasteurellaceae Species 0.000 title abstract 3
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 239000003053 toxin Substances 0.000 abstract 3
- 231100000765 toxin Toxicity 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/21—Haemophilus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invencion se refiere a bacterias productoras de toxina RTX atenuadas vivas de la familia Pasteurellaceae, de las cuales la atenuacion se debe al hecho de que producen toxina RTX en una forma no activada. La invencion también se refiere a vacunas para la proteccion de mamíferos contra infeccion con bacterias productoras de toxina RTX de la familia Pasteureliaceae y a métodos para al preparacion de dichas bacterias atenuadas vivas y vacunas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL96201557.4 | 1996-05-31 | ||
EP96201557 | 1996-05-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA97004061A MXPA97004061A (es) | 1998-04-01 |
MX9704061A true MX9704061A (es) | 1998-04-30 |
Family
ID=8224047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9704061A MX9704061A (es) | 1996-05-31 | 1997-06-02 | Bacterias productoras de rtx atenuadas vivas de la familia pasteurellaceae. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6770275B1 (es) |
JP (1) | JPH1075774A (es) |
KR (1) | KR970074928A (es) |
CN (1) | CN1117862C (es) |
AU (1) | AU720156B2 (es) |
CA (1) | CA2206575A1 (es) |
HU (1) | HU226219B1 (es) |
MX (1) | MX9704061A (es) |
NZ (1) | NZ314987A (es) |
TW (1) | TW546147B (es) |
ZA (1) | ZA974809B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060134225A (ko) * | 1999-04-09 | 2006-12-27 | 파마시아 앤드 업존 캄파니 엘엘씨 | 항균성 백신 조성물 |
US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
KR100807844B1 (ko) * | 2006-12-27 | 2008-02-27 | 주식회사 바이오리쏘스 | 약독화된 파스튜렐라 물토시다 균주, 그를 포함하는면역원성 조성물 및 그를 이용한 포유동물의 파스튜렐라물토시다 감염증의 치료 또는 예방하는 방법 |
ES2434829T3 (es) * | 2007-09-05 | 2013-12-17 | Genentech, Inc. | Péptidos que contienen arginina C-terminal biológicamente activos |
WO2015066292A1 (en) | 2013-11-01 | 2015-05-07 | Merial Limited | Attenuated pasteurella multocidavaccines & methods of making & use thereof |
EP3689373A1 (en) * | 2019-01-30 | 2020-08-05 | IDT Biologika GmbH | Inactivated apxia, apxiia and apxiiia toxins |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963487A (en) * | 1985-01-03 | 1990-10-16 | Massachusetts Institute Of Technology | Method for deletion of a gene from a bacteria |
US5165924A (en) | 1986-01-22 | 1992-11-24 | University Of Guelph | Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle |
GB8611832D0 (en) * | 1986-05-15 | 1986-06-25 | Holland I B | Polypeptide |
US5256415A (en) | 1989-03-20 | 1993-10-26 | Louisiana State University | Vaccine against bovine respiratory disease (pasteurellosis) |
GB8912330D0 (en) | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
US5641653A (en) | 1989-10-31 | 1997-06-24 | The Texas A&M University System | DNA encoding Actinobacillus pleuropneumoniae hemolysin |
CA2045950C (en) * | 1991-06-28 | 2004-05-11 | Elbarte M. Kamp | Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections |
US5422110A (en) * | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5587305A (en) * | 1993-12-06 | 1996-12-24 | The United States Of America As Represented By The Department Of Agriculture | Pasteurella haemolytica transformants |
WO1995025742A1 (en) * | 1994-03-22 | 1995-09-28 | Pfizer Inc. | Pasteurellaceae antigens and related vaccines |
AUPN631495A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(I) |
AU717773B2 (en) * | 1995-11-02 | 2000-03-30 | Commonwealth Scientific And Industrial Research Organisation | Immunity against pasteurella haemolytica leukotoxin |
AUPN631395A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(II) |
-
1997
- 1997-05-30 US US08/866,198 patent/US6770275B1/en not_active Expired - Lifetime
- 1997-05-30 CA CA002206575A patent/CA2206575A1/en not_active Abandoned
- 1997-05-30 HU HU9700975A patent/HU226219B1/hu not_active IP Right Cessation
- 1997-05-30 ZA ZA9704809A patent/ZA974809B/xx unknown
- 1997-05-30 JP JP9178792A patent/JPH1075774A/ja active Pending
- 1997-05-30 CN CN97114993A patent/CN1117862C/zh not_active Expired - Fee Related
- 1997-05-31 KR KR1019970022351A patent/KR970074928A/ko not_active Application Discontinuation
- 1997-06-02 AU AU24643/97A patent/AU720156B2/en not_active Ceased
- 1997-06-02 MX MX9704061A patent/MX9704061A/es not_active IP Right Cessation
- 1997-06-03 NZ NZ314987A patent/NZ314987A/en unknown
- 1997-12-03 TW TW086118161A patent/TW546147B/zh active
Also Published As
Publication number | Publication date |
---|---|
HU226219B1 (en) | 2008-06-30 |
TW546147B (en) | 2003-08-11 |
CN1173540A (zh) | 1998-02-18 |
AU2464397A (en) | 1997-12-04 |
CN1117862C (zh) | 2003-08-13 |
AU720156B2 (en) | 2000-05-25 |
CA2206575A1 (en) | 1997-11-30 |
ZA974809B (en) | 1998-01-23 |
KR970074928A (ko) | 1997-12-10 |
NZ314987A (en) | 2000-02-28 |
US6770275B1 (en) | 2004-08-03 |
HUP9700975A2 (hu) | 1998-05-28 |
HUP9700975A3 (en) | 2007-05-29 |
HU9700975D0 (en) | 1997-07-28 |
JPH1075774A (ja) | 1998-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO982310L (no) | Protegriner | |
BG100960A (en) | Dosage forms for controlled release of azitromycin | |
WO2003061558A3 (en) | Glycoconjugate vaccines for use in immune-compromised populations | |
PL328858A1 (en) | Immunogenous peptides | |
PL365453A1 (en) | Compounds and methods for the treatment and prevention of bacterial infection | |
AP1470A (en) | Attenuated microorganisms for the treatment of infection | |
EP0640097A4 (en) | COMPOSITION AND METHODS FOR VACCINATING AGAINST CORONAVIRES (01/20/94). | |
ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
EP0810283A3 (en) | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae | |
AU1794601A (en) | Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
WO1994010317A3 (en) | Conjugate vaccine against group b streptococcus | |
WO2002034773A3 (en) | Streptococcal genes | |
MX9704061A (es) | Bacterias productoras de rtx atenuadas vivas de la familia pasteurellaceae. | |
PL344851A1 (en) | Bacterium of salmonella type and vaccine containing that bacterium for protecting animals against salmonellosis and method of obtaining such vaccine | |
EP0837692A4 (es) | ||
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
TW200502384A (en) | Live attenuated bacteria of the species actinobacillus pleuropneumoniae | |
DE69306934T2 (de) | Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff | |
HU9801705D0 (en) | Streptococcus equi vaccine | |
EP0863981A4 (en) | DETECTION, PREVENTION AND TREATMENT OF PAPILLOMATOUS DIGITAL DERMATITIS | |
NO20022949L (no) | Attenuerte mikroorganismer for behandling av infeksjon | |
EP1123711A4 (en) | VACCINE PREPARATIONS CONTAINING AN ABRASIVE TOXIN | |
GB2313782A (en) | Method and vaccine for prevention of over-production of acid in the rumen or gut of animals | |
WO2002024223A3 (en) | Prevention and treatment of streptococcal and staphylococcal infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
PD | Change of proprietorship |
Owner name: INTERVET INTERNATIONAL B.V. |
|
MM | Annulment or lapse due to non-payment of fees |